KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) Other Operating Expenses: 2012-2025

Historic Other Operating Expenses for Precigen (PGEN) over the last 14 years, with Sep 2025 value amounting to $1.0 million.

  • Precigen's Other Operating Expenses rose 2.58% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year decrease of 71.74%. This contributed to the annual value of $44.6 million for FY2024, which is 163.01% up from last year.
  • Latest data reveals that Precigen reported Other Operating Expenses of $1.0 million as of Q3 2025, which was down 79.30% from $5.0 million recorded in Q2 2025.
  • Precigen's Other Operating Expenses' 5-year high stood at $35.6 million during Q2 2024, with a 5-year trough of $1.0 million in Q3 2024.
  • Its 3-year average for Other Operating Expenses is $6.2 million, with a median of $1.5 million in 2023.
  • As far as peak fluctuations go, Precigen's Other Operating Expenses crashed by 87.81% in 2021, and later skyrocketed by 1,995.40% in 2024.
  • Over the past 5 years, Precigen's Other Operating Expenses (Quarterly) stood at $1.6 million in 2021, then declined by 20.49% to $1.3 million in 2022, then soared by 870.01% to $12.2 million in 2023, then plummeted by 43.02% to $6.9 million in 2024, then climbed by 2.58% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $5.0 million for Q2 2025, and $1.1 million during Q1 2025.